| Name | (3aR,5S,6R,6aR)-2,2-dimethyl-6-(naphthalen-2-ylmethoxy)-3a,5,6,6a-tetrahydrofuro[2,3-d][1,3]dioxole-5-carbaldehyde | 
|---|
| Molecular Formula | C19H20O5 | 
|---|---|
| Molecular Weight | 328.35900 | 
| Exact Mass | 328.13100 | 
| PSA | 53.99000 | 
| LogP | 2.80030 | 
| 
                                
                                
                                
                                
                                
                                
                                 ~%  
                                    1057385-93-9  | 
                        
| Literature: ISIS PHARMACEUTICALS, INC.; SETH, Punit, P.; PRAKASH, Thazha, P.; SWAYZE, Eric, E. Patent: WO2011/156202 A1, 2011 ; Location in patent: Page/Page column 81; 82 ; | 
| 
                                
                                
                                
                                
                                
                                
                                 ~%  
                                    1057385-93-9  | 
                        
| Literature: ISIS PHARMACEUTICALS, INC.; SETH, Punit, P.; PRAKASH, Thazha, P.; SWAYZE, Eric, E. Patent: WO2011/156202 A1, 2011 ; | 
| 
                                
                                
                                
                                
                                
                                
                                 ~%  
                                    1057385-93-9  | 
                        
| Literature: ISIS PHARMACEUTICALS, INC.; SETH, Punit, P.; SWAYZE, Eric, E.; HANESSIAN, Stephen; SCHROEDER, Benjamin, R.; GIACOMETTI, Robert, D.; MERNER, Bradley, L. Patent: WO2013/154798 A1, 2013 ; | 
| 
                                
                                
                                
                                
                                
                                
                                 ~%  
                                    1057385-93-9  | 
                        
| Literature: ISIS PHARMACEUTICALS, INC.; Allerson, Charles; Bhat, Balkrishen; Swayze, Eric E. Patent: US2013/41011 A1, 2013 ; | 
| Precursor 4 | |
|---|---|
| DownStream 1 | |